MTAP DELETION
Clinical trials for MTAP DELETION explained in plain language.
Never miss a new study
Get alerted when new MTAP DELETION trials appear
Sign up with your email to follow new studies for MTAP DELETION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets tough cancers in groundbreaking trial
Disease control Recruiting nowThis study is testing whether a new oral drug called TNG462 is safe and effective when combined with other cancer drugs for people with advanced pancreatic or non-small cell lung cancer. The trial will involve about 183 adults whose cancers have specific genetic changes (MTAP los…
Matched conditions: MTAP DELETION
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cancer drug PEP08 enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people testing PEP08, a new oral cancer drug, for patients with advanced solid tumors that have a specific genetic change called MTAP deletion. The main goals are to find safe doses, see how the body processes the drug, and look for early signs that it …
Matched conditions: MTAP DELETION
Phase: PHASE1 • Sponsor: PharmaEngine • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC